Pharmaceuticals

Entrepreneurs

Harnessing the Power of Technology to Boost Prosperity: Pietro Paganini's Solution to a Balanced Lifestyle

The complexity of healthy, balanced lifestyles has been explored for centuries, and today's technology offers exciting opportunities.

News and Trends

IXP Launches INR 200 Cr Fund to Boost Biotech Innovation

The portfolio will comprise 20-25 B2B startups spanning Pre-seed to Series A stages, addressing innovation gaps in areas such as pharmaceuticals, biotechnology, medical technology, specialty chemicals, agrotechnology, and nutraceuticals.

News and Trends

India's Pharma Exports To Reach $350 Billion by 2047: Report

The global pharmaceutical industry is valued at approximately $1.6 trillion, while India's market stands at $55 billion, projected to grow to $120-130 billion by 2030.

Growth Strategies

How Sri Lanka's Pharmaceutical Sector Could Benefit from UAE-Based Mintiply Capital's Stake in Premium International Injectable

This offering presents investors with an opportunity to acquire a stake in a company poised to make significant contributions to Sri Lanka's pharmaceutical sector.

News and Trends

PAG Acquires Majority Stake in Pharma Packaging Player Pravesha Industries

This move underscores PAG's continued focus on India's burgeoning packaging industry, following its recent investment in Manjushree Technopack.

News and Trends

Northern Arc and Sai Life Look To Raise Funds Through IPO: Secures SEBI Green Light

Non-banking credit provider Northern Arc Capital and pharma company Sai Life Sciences, both have filed their respective draft papers with the Indian market regulator Securities and Exchange Board of India (SEBI) for a fundraising of a combined INR 7000 Crore.

News and Trends

Global Pharma Supplier Emcure hits IPO: To Be Listed on NSE AND BSE

The offer will comprise of a fresh issue of 79 Lakh shares which will raise close to INR 800 Crores. The price band is set at INR 960-1008 per share.

Growth Strategies

The Veteran Pharma Founders That Keep Buying Their Own NASDAQ Stock

Nuvectis Pharma CEO Ron Bentsur, a veteran in the pharma industry, has invested over $3 million into the company. Bentsur: "Our continued investment in Nuvectis reflects our unwavering belief in the transformative potential of our pipeline"

Leadership

The Pharm-er CEO: Sheetal Arora, Mankind Pharma

Pandemic was one of the toughest challenges for the company as it had to meet increased demand for products, remote work and create an IT infrastructure to support 15,000 people moving online, says, Sheetal Arora, CEO, Mankind Pharma

Business News

Walgreens Names New CEO, Unveils $1 Billion Cost-Cutting Plan—Including 60 Clinic Closures

Walgreens reported significant financial losses for its 2023 fiscal year, with operating losses reaching $6.9 billion.

Business News

A Popular Drug Store Chain Is Filing for Bankruptcy Amid Opioid Lawsuits and Financial Woes

The pharmacy chain Rite Aid first opened in Pennsylvania in 1962.

Business News

Novo Nordisk Is Worth More Than Denmark's GDP Thanks to America's Ozempic and Wegovy Craze

The pharmaceutical company Novo Nordisk has seen an unprecedented surge in profits, and has subsequently influenced the economy of Denmark, where the company is based.

Growth Strategies

Dr. Reddy's Reports Stellar First-Quarter Earnings

Dr. Reddy's Laboratories Limited (NSE: DRREDDY), a leading global pharmaceutical company headquartered in India, reported stellar first-quarter earnings on July 26, highlighting the progress it has made with its efforts to diversify into new drug verticals.

News and Trends

Emil Pharmaceuticals Secures INR 150 Crore: Report

The company plans to utilize the fund for rapid expansion and modernization of pharmaceutical formulations' capacities and increasing the footprints in the rest of the world as well as regulated markets

News and Trends

Alkem Becomes First Indian Company To Launch Novel Antibiotic For Multiple Drug Resistance (MDR) Infections

The available evidence suggests that Zidavi is a potential therapeutic option for the treatment of infections complicated by multi-drug resistant (MDR) organisms